AzTrials
AzTrials

Anesthesia and AnalgesiaNCT04336579

Diaphragmatic Breathing Exercises in Total Knee Arthroplasty Patients

An observational study of Anesthesia and Analgesia, run by University of Southern California at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Rationale: While total knee replacements (TKA) are one of the most commonly performed surgical procedures in the United States, this procedure can also be very painful. Postoperative mobilization and rehabilitation is vital to a patient's recovery, but inadequate pain control can impede patients' progress. Read more about this study

Who is it for?
Ages 50 to 90 years
Conditions the study is for
Anesthesia and Analgesia
What is being tested?
Diaphragmatic Breathing
How many people
50 participants
Where
1 siteUnited States
Study dates
10 Jun 2024to 1 Oct 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients (participants) undergoing total knee arthroplasty with placement of continuous peripheral nerve block catheter between the ages of 50-90 years of age at the Keck Hospital of USC who want to participate and consent to participate in the study. The control group will be made up of patients( 50-90 years of age) who underwent total knee arthroplasty with placement of a continuous peripheral nerve block catheter over the year prior, without participation in breathing exercises, at the Keck Hospital of USC.

Who may be able to join

  • Patients (participants) undergoing total knee arthroplasty with a continuous peripheral nerve block catheter

Who cannot join

  • Inability to perform or learn diaphragmatic breathing exercises or do not wish to participate in diaphragmatic breathing or study protocol
  • Pregnant patients
  • Patients without continuous peripheral nerve block catheter

Trial locations and contacts

1 site in 1 country.

Linda J Rever, MD contact

3234427400

rever@usc.edu

United States1 site, 1 recruiting
  • Keck Hospital of USC

    Los Angeles, California, 90033

    Recruiting

Other trials in United States

About this study

Official title: Diaphragmatic Breathing Exercises As An Analgesia Adjunct in Total Knee Arthroplasty Patients in the Perioperative Period

Rationale: While total knee replacements (TKA) are one of the most commonly performed surgical procedures in the United States, this procedure can also be very painful. Postoperative mobilization and rehabilitation is vital to a patient's recovery, but inadequate pain control can impede patients' progress. Diaphragmatic breathing is an additional non-pharmacological and non-invasive tool with no adverse effects that could aid in recovery. This will serve as a pilot study for a possible larger controlled trials.

Read the detailed description

Study population: Patients (participants) undergoing total knee arthroplasty at Keck USC Hospital at HC3

Study methodology: Patients (participants) will be taught with the aide of a handout and instructional videos preoperatively and in the recovery room on how to perform diaphragmatic breathing exercises for post-operative pain control. Patient (participant) pain levels will be assessed using the visual analog scale (VAS). The investigators will then be comparing VAS scores and daily opioid doses (morphine equivalents) between the study group and a control group. The control group will include prior patients (participants) over the past year who underwent TKA at Keck Hospital and also had pain scores and opioid usage measured, but did not receive the breathing treatment.

Study endpoints: Endpoints will include: pain levels via VAS scale, anxiety levels via VAS scale, and opioid usage (morphine equivalents).

Being tested
Diaphragmatic Breathing
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diaphragmatic BreathingBehavioural

    Simple diaphragmatic breathing exercise

Study groups in NCT04336579
Study groupRoleWhat they receive
ControlRetrospective review of patients (participants) with standard analgesia post total knee arthroplasty
Diaphragmatic BreathingIntervention: Participants will perform diaphragmatic breathing exercises postoperatively as part of their multi-modal pain regimen.
Receives: Behavioral: Diaphragmatic Breathing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Level

    Verbal Analog Pain Score - rate pain on 0-10 scale where 0=no pain, 10= worst possible pain

    Measured: Prior to intervention

  2. Opioid Usage (morphine equivalents)

    Opioid Usage for pain

    Measured: Prior to intervention

  3. Anxiety Level

    Verbal Analog Score -rate anxiety on 0-10 scale where 0= no anxiety, 10= worst possible anxiety

    Measured: Prior to intervention

  4. Pain Level

    Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain

    Measured: 15 minutes after intervention

  5. Opioid Usage (morphine equivalents)

    Opioid Usage for pain

    Measured: 15 minutes after intervention

  6. Anxiety Level

    Verbal Analog Score - rate anxiety on 0-10 scale where 0 =no anxiety, 10 = worst possible anxiety

    Measured: 15 minutes after intervention

  7. Pain Level

    Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain

    Measured: 6 hours after intervention

  8. Opioid Usage (morphine equivalents)

    Opioid Usage for pain

    Measured: 6 hours after intervention

  9. Anxiety Level

    Verbal Analog Score- rate anxiety on 0-10 scale where 0 =no anxiety, 10 = worst possible anxiety

    Measured: 6 hours after intervention

  10. Pain Level

    Verbal Analog Pain Score - rate pain on 0-10 scale where 0 =no pain, 10 = worst possible pain

    Measured: 1 day after intervention

  11. Opioid Usage (morphine equivalents)

    Opioid Usage for pain

    Measured: 1 day after intervention

  12. Anxiety Level

    Verbal Analog Score - rate anxiety on 0-10 scale where 0 = no anxiety, 10 = worst possible pain

    Measured: 1 day after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2020
  2. Study start10 Jun 2024
  3. Primary completion1 Oct 2024 (estimated)
  4. Study completion1 Oct 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Other
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04336579
Sponsor's protocol ID
HS-19-00223
Status last verified
Aug 2024
First submitted
19 Dec 2019
Last updated
27 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia and Analgesia, run by University of Southern California at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Linda J Rever, MD (3234427400, rever@usc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Level (time frame: Prior to intervention). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in